LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (“Obagi” or the “Company”) (NASDAQ:OMPI), a leader in topical aesthetic and therapeutic skin health systems, today confirmed that Voce Capital has submitted to the Company a notice of intent to nominate a slate of candidates to replace the Obagi Board of Directors at the Company’s 2013 Annual Meeting of Stockholders.
